4.4 Review

An overview of the protein tyrosine phosphatase superfamily

期刊

CURRENT TOPICS IN MEDICINAL CHEMISTRY
卷 3, 期 7, 页码 739-748

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568026033452302

关键词

-

资金

  1. NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048506] Funding Source: NIH RePORTER
  3. NCI NIH HHS [CA69202] Funding Source: Medline
  4. NIAID NIH HHS [AI48506] Funding Source: Medline

向作者/读者索取更多资源

The human genome encodes approximately 100 phosphatases that belong to the protein tyrosine phosphatase (PTP) superfamily, whose substrates range from proteins to phosphoinositides and mRNAs. The hallmark for this superfamily is the active site sequence C(X)5R, also known as the PTP signature motif. The PTPs are key regulatory components in signal transduction pathways and the importance of PTPs in the control of cellular signaling is well established. Furthermore, there are compelling reasons to believe that PTP inhibitors may serve as novel medicinal agents for the treatment of various diseases. Based on structure and substrate specificity, the PTP super-family is divided into four distinct subfamilies: 1) pTyr specific PTPs, 2) dual specificity phosphatases, 3) Cdc25 phosphatases, and 4) LMW PTPs. The PTPs have similar core structures made of a central parallel beta-sheet with flanking alpha-helices containing a beta-loop-alpha loop that encompasses the PTP signature motif. Not surprisingly, they employ a common chemical mechanism for phosphate hydrolysis despite the differences in substrate specificity. Despite the conserved structural and catalytic properties, there are also sufficient differences in the active site pockets and its immediate surrounding environment among different PTPs. Further structural and mechanistic study will continue to be of considerable importance, providing a solid basis for inhibitor design.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据